The case for requiring graphic warning labels on smokeless tobacco product packages

Annals of the American Thoracic Society

Volumn 13, Issue 3, 2016, Pages 329-333

  Pakhale, Smita ^a   Samet, Jonathan ^b   Folan, Patricia ^c   Leone, Frank ^d   White, Alexander ^e  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e New England Sinai Hosp Rehab Ctr   (United States)

Author keywords

Citizen engagement; Nicotine; Patient education; Patient engagement; Smoking

Indexed keywords

TOBACCO SMOKE;

APNEA; ARTICLE; ASIA; CARDIOVASCULAR DISEASE; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; ESOPHAGUS CANCER; FOOD AND DRUG ADMINISTRATION; HUMAN; LOW INCOME COUNTRY; MARKETING; MIDDLE INCOME COUNTRY; MOUTH CANCER; PANCREAS CANCER; PREMATURITY; SMALL FOR DATE INFANT; SMOKELESS TOBACCO; SMOKING; SMOKING BAN; SMOKING CESSATION; STILLBIRTH; TOBACCO INDUSTRY; EPIDEMIOLOGY; HARM REDUCTION; LEGISLATION AND JURISPRUDENCE; PACKAGING; UNITED STATES;

HARM REDUCTION; HUMANS; PRODUCT LABELING; SMOKING; SMOKING CESSATION; TOBACCO INDUSTRY; TOBACCO, SMOKELESS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84989163909     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201512-814PS     Document Type: Article

References (33)

1. U.S. Food and Drug Administration. FDA issues first product marketing orders through premarket tobacco application pathway. 2015. Available from: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm472026.htm
2. World Health Organization International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans volume 89: smokeless tobacco and some tobacco-specific N-nitrosamines. Lyon, France: The World Health Organization. 2007. Available from: http://monographs.iarc.fr/ENG/recentpub/mono89. pdf
3. World Health Organization. Tobacco free initiative (TFI). GATS (Global Adult Tobacco Survey) India Report 2009-2010. 2012.
4. U S Department of Health and Human Services. The health consequences of smoking-50 years of progress: a report of the Surgeon General, 2014. 2014. Available from: http://www. surgeongeneral.gov/library/reports/50-years-of-progress/index.html
5. Centers for Disease Control and Prevention. State-specific prevalence of cigarette smoking and smokeless tobacco use among adults-United States, 2009. MMWR Morb Mortal Wkly Rep 2010:59:1400-1406.
6. Nemeth JM, Liu ST, Klein EG, Ferketich AK, Kwan MP, Wewers ME. Factors influencing smokeless tobacco use in rural Ohio Appalachia. J Community Health 2012;37:1208-1217.
7. Mejia AB, Ling PM. Tobacco industry consumer research on smokeless tobacco users and product development. Am J Public Health 2010;100:78-87.
8. Hamari AK, Toljamo TI, Kinnula VL, Nieminen PA. Dual use of cigarettes and Swedish snuff (snus) among young adults in Northern Finland. Eur J Public Health 2013;23:768-771.
9. Tomar SL, Alpert HR, Connolly GN. Patterns of dual use of cigarettes and smokeless tobacco among US males: findings from national surveys. Tob Control 2010;19:104-109.
10. Physicians for a Smoke-Free Canada. The snus experience: lessons from Sweden, Norway and Canada on the public health consequences of widespread oral tobacco use. 2007. Available from: http://www.smoke-free.ca/pdf-1/snus-comparative-experiences.pdf
11. U.S. Department of Health and Human Services. The health consequences of smoking-50 years of progress: a report of the Surgeon General. 2014 [accessed 2014 Sept 8]; Available from: http://www.surgeongeneral.gov/library/reports/50-years-ofprogress/ exec-summary.pdf
12. Carpenter CM, Connolly GN, Ayo-Yusuf OA, Wayne GF. Developing smokeless tobacco products for smokers: an examination of tobacco industry documents. Tob Control 2009;18:54-59.
13. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Preventing tobacco use among youth and young adults: a report of the Surgeon General. 2012. Available from: http://www. surgeongeneral.gov/library/reports/preventing-youth-tobacco-use/ full-report.pdf
14. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224-2260.
15. World Health Organization. WHO report on the global tobacco epidemic, 2011: warning about the dangers of tobacco. 2011. Available from: http://www.who.int/tobacco/global-report/2011/en/
16. Baba S, Wikström AK, Stephansson O, Cnattingius S. Changes in snuff and smoking habits in Swedish pregnant women and risk for small for gestational age births. BJOG 2013;120:456-462.
17. Ayo-Yusuf OA, Burns DM. The complexity of 'harm reduction' with smokeless tobacco as an approach to tobacco control in lowincome and middle-income countries. Tob Control 2012;21:245-251.
18. Severson HH, Forrester KK, Biglan A. Use of smokeless tobacco is a risk factor for cigarette smoking. Nicotine Tob Res 2007;9: 1331-1337.
19. Tomar SL. Is use of smokeless tobacco a risk factor for cigarette smoking? The U.S. experience. Nicotine Tob Res 2003;561-569.
20. Grøtvedt L, Forsén L, Stavem K, Graff-Iversen S. Patterns of snus and cigarette use: a study of Norwegian men followed from age 16 to 19. Tob Control 2013;22:382-388.
21. Ramström L, Wikmans T. Mortality attributable to tobacco among men in Sweden and other European countries: an analysis of data in a WHO report. Tob Induc Dis 2014;12:14.
22. Capella ML, Taylor CR, Kees JERE. Tobacco harm reduction advertising in the presence of a government-mandated warning. J Consum Aff 2012;46:235-259.
23. Alpert HR, Koh H, Connolly GN. Free nicotine content and strategic marketing of moist snuff tobacco products in the United States: 2000-2006. Tob Control 2008;17:332-338.
24. Peeters S, Gilmore AB. How online sales and promotion of snus contravenes current European Union legislation. Tob Control 2013; 22:266-273.
25. Biener L, McCausland K, Curry L, Cullen J. Prevalence of trial of snus products among adult smokers. Am J Public Health 2011;101: 1874-1876.
26. The reports of the Surgeon General: the health consequences of using smokeless tobacco. 1986 Apr 4.
27. World Health Organization. FCTC Article 11. Tobacco warning labels: evidence and recommendations from the ITC Project. WHO Framework Convention on Tobacco Control. 2009. Available from: http://www.roswelltturc.org/warnings/ITCwarningreport.pdf
28. Smokeless Tobacco Product Warning Labels-Fact Sheet.
29. Brubaker RG, Mitby SK. Health-risk warning labels on smokeless tobacco products: are they effective? Addict Behav 1990;15: 115-118.
30. Callery WE, Hammond D, O'Connor RJ, Fong GT. The appeal of smokeless tobacco products among young Canadian smokers: the impact of pictorial health warnings and relative risk messages. Nicotine Tob Res 2011;13:373-383.
31. Centers for Disease Control and Prevention. Cigarette package health warnings and interest in quitting smoking-14 countries, 2008-2010. Morbidity and Mortality Weekly Report (MMWR). 2011. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6020a2. htm
32. Pakhale S, Leone F, White AC; Tobacco Action Committee of the American Thoracic Society. The argument in favor of graphic warning labels on cigarette packages. Ann Am Thorac Soc 2013;10:50-52.
33. Cortese DK, Ling PM. Enticing the new lad: masculinity as a product of consumption in tobacco industry-developed lifestyle magazines. Men Masc 2011;14:4-30.